Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-26 Disposition | 2024-01-26 4:36 pm | N/A N/A | Rain Oncology Inc. | RAIN | Doebele Robert See Remarks | 474,436 | $0 | 0 (Direct) | View |
| 2024-01-26 Equity Swap | 2024-01-26 4:36 pm | N/A N/A | Rain Oncology Inc. | RAIN | Doebele Robert See Remarks | 476,827 | $0 | 0 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:16 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Doebele Robert See Remarks | 149,100 | $0 | 149,100 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 6:18 pm | N/A 2033-02-15 | Rain Oncology Inc. | RAIN | Doebele Robert See Remarks | 123,325 | $0 | 123,325 (Direct) | View |
| 2022-07-06 Exercise | 2022-07-07 6:02 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,890 | $3.95 | 481,827 (Direct) | View |
| 2022-07-06 Exercise | 2022-07-07 6:02 pm | N/A 2029-03-13 | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,890 | $0 | 481,827 (Direct) | View |
| 2022-04-13 Exercise | 2022-04-15 4:30 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,000 | $3.95 | 481,827 (Direct) | View |
| 2022-04-13 Exercise | 2022-04-15 4:30 pm | N/A 2029-03-13 | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,000 | $0 | 481,827 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:15 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 2,000 | $3.95 | 481,827 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:15 pm | N/A 2029-03-13 | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 2,000 | $0 | 481,827 (Direct) | View |
| 2022-01-07 Option Award | 2022-02-04 4:35 pm | N/A 2032-01-07 | Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer | 72,000 | $0 | 72,000 (Direct) | View |
| 2021-04-27 Conversion | 2021-04-27 5:04 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer | 10,259 | $0 | 467,937 (Direct) | View |
Ownership | 2021-04-22 7:12 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer | 0 | $0 | 606,838 (Direct) | View |